However, there was no significant correlation between the high TUG1 levels and gender (OR = 1.04, 95% CI: 0.77–1.42, P = 0.774) or age (OR = 0.75, 95% CI: 0.51–1.10, P = 0.136) or lymph node metastasis (OR = 1.45, 95% CI: 0.85–2.50, P = 0.177) or clinical TNM stage (OR = 0.55, 95% CI: 0.17–1.81, P = 0.326) (Table 3). Here, TUG1 is linked to metastatic malignant neoplasm in the lymph nodes.